Members

Why Alibaba Group Holding Ltd (NYSE:BABA) stock will rise 60% the next two years

Alibaba Group Holding Ltd (NYSE:BABA) Cloud Computing could be the equivalent to AWS for AMZN stock to BABA stock. This coupled with Ant Financial and ongoing growth bodes well for Alibaba stock owners the next few years.

Also posted in HADE Platform, Hot Stocks, Technology | | Tagged , , , | 1 Comment

32% crash in Sibanye Gold (NYSE:SBGL) stock creates perfect buying opportunity with Stillwater acquisition complete

SBGL stock fell 32% after terms of a debt agreement to acquire Stillwater Mining creates dilution at cheap valuation. Sibanye Gold (NYSE:SBGL) still a buy?

Also posted in Basic Materials, Editor's Pick, Timely Analysis | | Tagged , | Leave a comment

5 reasons Ford stock’s collapse is no surprise

A lot of uncertainty regarding Ford Motor Company (NYSE:F) direction, and rightfully so. Ford stock fell to another 52-week low.

Also posted in HADE Platform, Industrials | | Tagged , , , , | 2 Comments

Why an Amazon (AMZN) & DISH Network partnership will cause big problems for AT&T, Verizon (VZ), T-Mobile (TMUS), and Sprint (S)

If Amazon.com (NASDAQ:AMZN) and DISH partner, don’t be surprised if free wireless for all Prime members is next. Great for AMZN stock owners.

Also posted in Editor's Pick, HADE Platform, Technology | | Tagged , , , , , , , , , | 4 Comments

How Valeant Pharmaceuticals can unlock 300% gains in VRX stock

By divesting B&L and Salix, Valeant Pharmaceuticals could unlock gains of 300% in VRX stock. Here’s why Valeant stock owners should welcome the deal.

Also posted in HADE Platform, Healthcare & Biotech | | Tagged , | 2 Comments

Proof that Facebook (NASDAQ:FB) is responsible for Yelp stock struggles

Yelp stock has crashed behind a rapid growth reduction in all meaningful metrics, in large part thanks to Facebook Inc (NASDAQ:FB).

Also posted in HADE Platform, Technology | | Tagged , , | 3 Comments

3 reasons Celgene Corporation (NASDAQ:CELG) stock owners should not worry about Revlimid

Revlimid sales will remains a catalyst for CELG stock and a big part of Celgene Corporation’s (NASDAQ:CELG) outlook, but there’s more to Celgene stock.

Also posted in HADE Platform, Healthcare & Biotech | | Tagged , | Leave a comment